SCHEMBL4640658

SCHEMBL4640658

CCCCC(OC(=O)c1ccc(CC)cc1C(=O)OC(CCCC)C(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
TSHR P16473 3/20 0.43
MAPK1 P28482 3/20 0.43
CYP3A4 P08684 2/20 0.39
CA2 P00918 2/20 0.39
CTSL P07711 1/20 0.39
CTSB P07858 1/20 0.39
CTSH P09668 1/20 0.39
CTSK P43235 1/20 0.39
AKR1C3 P42330 1/20 0.38
AKR1C2 P52895 1/20 0.38
PRKCA P17252 1/20 0.37
PRKCD Q05655 1/20 0.37
ALOX15 P16050 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
TP53 P04637 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
PRSS1 P07477 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640665 0.93 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4644332 0.86 ALDH1A1 (0.43) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4639887 0.85 ALDH1A1 (0.40) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4639856 0.85 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4639917 0.85 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4640242 0.83 ALDH1A1 (0.41) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4639936 0.82 ALDH1A1 (0.40) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4640011 0.82 ALDH1A1 (0.42) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4640631 0.81 ALDH1A1 (0.39) ALDH1A1TSHRMAPK1CYP3A4CA2
SCHEMBL4641126 0.81 ALDH1A1 (0.39) ALDH1A1TSHRMAPK1CYP3A4CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX ALDH1A1 725/4885TSHR 4817/4885MAPK1 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.